Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Susan M. Sinclair"'
Publikováno v:
Rheumatology and Therapy, Vol 7, Iss 3, Pp 601-615 (2020)
Abstract Introduction Primary Sjögren’s syndrome (pSS) is a complex, heterogenous autoimmune disease; no immunomodulatory drug has demonstrated efficacy, and no current treatments target the underlying cause. This study aimed to explore the diseas
Externí odkaz:
https://doaj.org/article/20f0da3309324e33805b02a4699a7c64
Autor:
Susan M. Sinclair, Judith K. Jones, Richard K. Miller, Michael F. Greene, Paul Y. Kwo, Willis C. Maddrey
Publikováno v:
Birth defects researchREFERENCES. 114(20)
Significant teratogenic effects have been demonstrated for ribavirin in animal studies. Ribavirin is prescribed for chronic hepatitis C and is contraindicated in pregnant women and their male sexual partners. Both are advised to avoid pregnancy for 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87271c0189bdfdd3f11dc3ba312e0589
https://pubmed.ncbi.nlm.nih.gov/36305304
https://pubmed.ncbi.nlm.nih.gov/36305304
Autor:
Paul Y. Kwo, Richard K. Miller, Willis C. Maddrey, Judith K. Jones, Michael F. Greene, Susan M. Sinclair
Publikováno v:
Drug safety. 40(12)
Significant teratogenic effects have been demonstrated in all animal species exposed to ribavirin. Ribavirin is prescribed for chronic hepatitis C and is contraindicated in women who are pregnant and in the male sexual partners of women who are pregn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6341216dcdadc806a45befdcbb9ba1a0
https://pubmed.ncbi.nlm.nih.gov/28913820
https://pubmed.ncbi.nlm.nih.gov/28913820
Autor:
Richard I. Lowensohn, Marianne Cunnington, Susan M. Sinclair, John G. Weil, Janet D. Cragan, Patricia Tennis, Mark Yerby, John Messenheimer
Publikováno v:
Pharmacoepidemiology and Drug Safety. 23:779-786
Purpose The International Lamotrigine Pregnancy Registry monitored for a signal of a substantial increase in the frequency of major congenital malformations associated with lamotrigine exposures in pregnancy over an 18-year period. Key methodological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf413648ea380fc2c7949a564446d169
https://doi.org/10.1002/pds.3659
https://doi.org/10.1002/pds.3659
Autor:
Susan M. Sinclair, Sara A. Ephross
Publikováno v:
Headache: The Journal of Head and Face Pain. 54:1158-1172
Objectives To monitor for a signal of major teratogenicity by determining the risk of all birth major defects following in utero exposure to sumatriptan, naratriptan, and the sumatriptan/naproxen sodium combination product (tablets marketed in the Un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3287a76af1502064d28cc84562716f4a
https://doi.org/10.1111/head.12375
https://doi.org/10.1111/head.12375
Autor:
Harold Campbell, Jared G. Kerr, Susan M. Sinclair, Robert W. Boyce, David J. Giordano, Justine J. Reel
Publikováno v:
Journal of General Practice.
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States [1]. COPD is a complex disease for which the cause and cure remain elusive. Conventional treatments for COPD have traditionally included medications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73571186a8cfef98a31d2ad3fb144e97
https://doi.org/10.4172/2329-9126.1000247
https://doi.org/10.4172/2329-9126.1000247
Publikováno v:
Journal of midwiferywomen's health. 61(1)
Nearly 90% of women in the United States have taken medications during pregnancy. Medication exposures during pregnancy can result in adverse pregnancy and neonatal outcomes including birth defects, fetal loss, intrauterine growth restriction, premat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a051b540e484e7059c15f125dbc5bd9b
https://pubmed.ncbi.nlm.nih.gov/26771055
https://pubmed.ncbi.nlm.nih.gov/26771055
Publikováno v:
Value in Health. 19:A559
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1f17a2e7f6be0030ac4da769c72523a
https://doi.org/10.1016/j.jval.2016.09.1231
https://doi.org/10.1016/j.jval.2016.09.1231